32536773
2020 May 7
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and has been considered a very immunogenic tumor. The treatment with radiofrequency ablation (RFA) has been established as the standard ablative therapy for early HCC, and is currently recognized as the main ablative tool for HCC tumors
Combined modality therapy; Hepatocellular carcinoma; Immunotherapy; Liver cancer; Radiofrequency ablation; State-of-the-art review.
